Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
12.69
+0.18 (1.44%)
Jan 17, 2025, 4:00 PM EST - Market closed
Rapport Therapeutics Market Cap
Rapport Therapeutics has a market cap or net worth of $464.16 million as of January 17, 2025.
Market Cap
464.16M
Enterprise Value
145.15M
1-Year Change
n/a
Ranking
Category
Stock Price
12.69
Market Cap Chart
Since the IPO on June 7, 2024, Rapport Therapeutics's market cap has decreased from $601.40M to $464.16M, a decrease of -22.82%. That is a compound annual growth rate of -34.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 464.16M | -28.47% |
| Dec 31, 2024 | 648.87M | 7.89% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |